Search for Clinical Trial Results
Myelofibrosis - 57 Studies Found
Status | Study |
Not yet recruiting |
Study Name: A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis Condition: Myelofibrosis Date: 2017-05-05 Interventions:
|
Terminated |
Study Name: Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis Condition: Myelofibrosis Date: 2008-04-24 Interventions: Drug: bevacizumab (Avastin) 15 mg/kg of bevacizumab by IV infusion once every 3 weeks (1 cycle) for 12 w |
Active, not recruiting |
Study Name: Allogeneic Stem Cell Transplantation for Myelofibrosis Condition: Myelofibrosis Date: 2007-05-15 Interventions:
|
Active, not recruiting |
Study Name: Study of Ruxolitinib for Patients With Myelofibrosis (MF) Condition: Myelofibrosis Date: 2016-05-20 Interventions:
|
Recruiting |
Study Name: A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Condition: Myelofibrosis Date: 2016-03-21 Interventions:
|
Completed |
Study Name: Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients Condition: Myelofibrosis Date: 2011-04-21 Interventions: Drug: Ruxolitinib Ruxolitinib was supplied as SR and IR formulated tablets. |
Recruiting |
Study Name: Quantitative MRI for Myelofibrosis Condition: Myelofibrosis Date: 2013-10-25 Interventions: Procedure: T1 Weighted MRI (magnetic resonance imaging) En |
Completed |
Study Name: Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis Condition: Myelofibrosis Date: 2007-12-11 Interventions: Drug: Fludarabine, Melphalan +/- ATG Conditioning regimen |
Suspended |
Study Name: Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor Condition: Primary Myelofibrosis Date: 2015-04-21 Interventions:
|
Recruiting |
Study Name: Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis Condition: Myelofibrosis Date: 2015-02-06 Interventions:
|